Dgs Capital Management, LLC Bausch Health Companies Inc. Transaction History

Dgs Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 10, 2024	SELL	$5.22 - $8.26 $52,309 - $82,773	-10,021 Closed	0 $0
Q2 2024 Dec 10, 2024	BUY	$6.1 - $10.41 $61,128 - $104,318	10,021 New	10,021 $69,000
Q4 2023 Jan 30, 2024	SELL	$6.53 - $8.23 $4,525 - $5,703	-693 Reduced 5.84%	11,177 $89,000
Q3 2023 Jan 30, 2024	SELL	$7.69 - $9.71 $3,721 - $4,699	-484 Reduced 3.92%	11,870 $97,000
Q2 2023 Jan 30, 2024	SELL	$5.72 - $8.8 $15,873 - $24,420	-2,775 Reduced 18.34%	12,354 $98,000
Q1 2023 Jun 16, 2023	BUY	$6.28 - $9.85 $95,010 - $149,020	15,129 New	15,129 $122,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Dgs Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dgs Capital Management, LLC with notifications on news.